Electrocardiographic diagnosis of left ventricular hypertrophy: depolarization changes

Journal of Electrocardiology

Volumn 42, Issue 3, 2009, Pages 228-232

  Bacharova, Ljuba ^a   Estes, E Harvey ^b  

^a INTERNATIONAL LASER CENTER   (Slovakia)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ELECTRIC POTENTIAL; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; ELECTRODIAGNOSIS; ELECTROPHYSIOLOGY; HEART DEPOLARIZATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; HEART RHYTHM; HEART VENTRICLE REMODELING; HUMAN; PRIORITY JOURNAL; QRS COMPLEX; SPECTROSCOPY;

DIAGNOSIS, DIFFERENTIAL; ELECTROCARDIOGRAPHY; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; VENTRICULAR DYSFUNCTION, LEFT;

EID: 65249136532     PISSN: 00220736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jelectrocard.2009.03.005     Document Type: Article

References (30)

1. The 6th report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 157 (1997) 2413
2. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206
3. Einthoven W. Le telecardiogramme. Arch Int Physiol 4 (1906-1907) 132
4. Scher A.M. Electrocardiographic theory and recording. In: Schlant R.C., and Hurst J.W. (Eds). Advances in electrocardiography vol. 2 (1976), Grune & Stratton, New York 3
5. Uhley H.N. Study of the transmembrane action potential, electrogram, electrocardiogram and vectorcardiogram of rats with left ventricular hypertrophy. Am J Cardiol 7 (1961) 211
6. Cabrera E., Estes E.H., and Hellerstein H.K. In: Hurst J.W., and Wenger N.K. (Eds). Electrocardiographic interpretation (1963), The Blakiston Division - McGraw-Hill Book Co, New York 49
7. Estes E.H. Chapter 6: electrocardiography and vectorcardiography. In: Hurst J.W., and Logue R.B. (Eds). The heart (1966), The Blakiston Division McGraw-Hill Book Company, New York 130
8. Fuster V., Alexander R.W., and O'Rourke R.A. Hurst's the heart (2004), Mc-Graw-Hill Medical Publishing Division, New York
9. Bacharova L. Electrical and structural remodeling in left ventricular hypertrophy-a substrate for a decrease in QRS voltage?. ANE 12 (2007) 260
10. Kannel W.B., Gordon T., Castelli W.P., and Margolis J.R. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease: the Framingham Study. Ann Intern Med 72 (1970) 813
11. Rautaharju P.M., LaCroix A.Z., Savage D.D., et al. Electrocardiographic estimate of left ventricular mass versus radiographic cardiac size and the risk of cardiovascular disease mortality in the epidemiological follow-up study of the first National Health and Nutrition Examination Survey. Am J Cardiol 62 (1988) 59
12. Verdecchia P., Porcellati C., Reboldi G., et al. Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension. Circulation 104 (2001) 2039
13. Gonzales-Juanatey J.R., Cea-Calvo L., Bertomeu V., and Aznar J. Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIID study. Rev Esp Cardiol 60 (2007) 148
14. De Bacquer D., De Backer G., Kornitzer M., et al. Prognostic value of ECG findings for total, cardiovascular disease, and coronary heart disease death in men and women. Heart 80 (1998) 570
15. Zimetbaum P.J., Buxton A.E., Batsford W., et al. Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial. Circulation 110 (2004) 766
16. Okin P.M., Wachtell K., Devereux R.B., et al. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. JAMA 296 (2006) 1242
17. Mathew J., Sleight P., Lonn E., et al. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation 104 (2001) 1615
18. Schneider M.P., Klingbeil A.U., Delles C., et al. Effect of irbersartan versus atenolol on left ventricular mass and voltage. Results of the CardioVascular Irbesartan Project. Hypertension 44 (2004) 61
19. Wachtell K., Okin P.M., Olsen M.H., et al. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study. Circulation 116 (2007) 700
20. Okin P.M., Devereux R.B., Jern S., Kjeldsen S.E., Julius S., and Dahlöf B. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) in Hypertension Study. The Life Study Investigators. Hypertension 36 (2000) 766
21. Okin P.M., Devereux R.B., Gerdts E., et al. LIFE Study Investigators. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study. Circulation 113 (2006) 1588
22. Horan L.G. Manifest orientation: the theoretical link between the anatomy of the heart and the clinical electrocardiogram. J Am Coll Cardiol 9 (1987) 1049
23. Mashima S. Theoretical considerations on the electrocardiogram of ventricular hypertrophy. J Electrocardiol 9 (1976) 133
24. Kleber A.G., and Rudy J. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol Rev 84 (2004) 431
25. Spach M.S., Heidlage J.F., Dolber P.C., and Barr R.C. Electrophysiological effects of remodeling cardiac gap junctions and cell size. Experimental and model studies of normal cardiac growth. Circ Res 86 (2000) 302
26. Spach M.S., and Barr R.C. Effects of cardiac microstructure on propagating electrical waveforms. Circ Res 86 (2000) e23
27. Tomaselli F.G., and Marban E. Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res 42 (1999) 270
28. Nattel S., and Li D. Ionic remodeling in the heart. Pathophysiological significance and new therapeutic opportunities for atrial fibrillation. Circ Res 87 (2000) 440
29. Akazawa H., and Komuro I. Roles of cardiac transcription factors in cardiac hypertrophy. Circ Res 92 (2003) 1079
30. Abildskov J.A., and Green L.S. The recognition of arrhythmia vulnerability by body surface electrocardiographic mapping. Circulation 75 Suppl III (1987) III-79